HNGE earnings analysis
What we found in HNGE's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Hinge Health reported strong Q1 2026 results with revenue at $182.3 million, up 47% year-over-year, and exceeding expectations of $172.2 million. EPS came in at $0.45, surpassing estimates of $0.34. Management highlighted continued growth in their client base and a positive outlook for future performance, raising the full-year revenue guidance by $64 million to nearly $800 million, driven by strong momentum in existing client engagement.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Significant Revenue Growth
- Q1 2026 revenue increased by 47% YoY to $182.3 million, surpassing expectations.
- Strong EPS Performance
- Reported EPS of $0.45 exceeded consensus estimates of $0.34 by 32%.
- Increased Cash Flow
- Operating cash flow improved notably to $43.1 million from $4.9 million last year.
- Enhanced Gross Margin
- Gross margin expanded to 85% from 81% YoY, driven by operational efficiencies.
- Robust Client Base Growth
- Client base grew to 2,849 from 2,311 a year earlier, enhancing future revenue potential.
- Raised Revenue Guidance
- Management raised full-year revenue guidance to $798-$804 million, reflecting strong client engagement.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Regulatory Compliance Risks
- Increased scrutiny by regulators could pose challenges for compliance, impacting operations.
- Dependence on Key Clients
- Revenue from top three partners accounted for 39.7%, posing a risk if relationships change.
- Market Sensitivity to Economic Conditions
- Ongoing economic fluctuations may affect client budgets, impacting demand for services.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $0.45
- Gross margin
- 85%
- Operating margin
- 17%
What they said about what is next.
Management anticipates continued strong performance driven by existing client base engagement.
The filing reads better than the one before it.
What came before.
- 10-K · March 3, 2026
- Hinge Health’s 2025 10-K emphasizes an AI‑led, software-first MSK care platform (TrueMotion, HingeConnect, Enso, HingeSelect) and a partner-driven go‑to‑market. The company showed a late‑2025 financial inflection with…
- 10-Q · August 11, 2025
- Hinge Health reported strong top-line growth with revenue of $139,098 (in thousands) for the quarter (up from $89,825 in Q2 2024) and higher gross profit of $97,763 (in thousands). However, operating expenses ballooned…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing HNGE makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever